What is the recent lead time for imported exosome extraction kits? How do domestic alternatives perform?

Recently, a lead time of three to four weeks for imported exosome kits is considered normal, and cold-chain customs clearance may cause further delays of a few days. Before purchasing, have the distributor confirm whether the product is in domestic stock or requires overseas replenishment, and clarify the shipping batch, shelf life, and storage temperature. Thermo precipitation-based serum/plasma kits and QIAGEN membrane affinity columns often have different catalog numbers, and their lead times may also differ, so do not rely solely on the catalog number. It is recommended to place import orders in batches rather than waiting for the same batch to arrive all at once and delaying experiments; first use domestic small-pack kits for cell supernatant, then process critical samples once the imported products arrive. Upon arrival, immediately open the package and check the temperature records. If the temperature of the precipitation solution stored at 4°C is abnormal, contact the supplier for return or exchange.

If the experiment schedule is tight, it is recommended to proceed with both imported and domestic options simultaneously: continue placing orders for the imported product but accept the lead time, while purchasing a small package of the domestic product first for cell supernatant, and wait for the imported product to arrive for complex samples. After the domestic product arrives, do not rush to use it in large quantities. Take one tube of known exosomes or the same batch of cell supernatant, repeat twice according to the instructions, and check the pellet amount, protein concentration, and WB. If a domestic alternative is needed for urine samples, prioritize models with column-based purification or membrane affinity steps rather than simple polymer precipitation. When negotiating with the distributor, ask clearly whether cold chain transport records, lot numbers, and storage conditions can be provided, as repeated freeze-thaw cycles of the reagent may affect extraction stability.

Whether domestic alternatives perform well cannot be judged solely by purity data; parallel validation on your own sample types is necessary. Cell culture supernatant is relatively straightforward, and imported and domestic precipitation methods may show little difference in WB markers; urine samples, however, are more complex, as changes in pH and salinity and Tamm-Horsfall protein can cause significantly elevated contaminating proteins in some precipitation-based kits. It is advisable to choose a brand that offers different protocols for "cell culture supernatant" and "urine." Before switching, extract the same batch of urine samples and cell culture supernatant separately, and compare NTA particle count, main particle size peak, protein concentration, and CD63/TSG101/Calnexin. For batch-to-batch stability, at least one batch should be sampled and tested in triplicate to see whether the CV is acceptable.

Cell culture supernatant and urine cannot be compared in the same way. If exosome-depleted serum is used for cell culture supernatant, the background is relatively clean, and domestic precipitation-based kits are usually sufficient; urine, however, contains large amounts of uromodulin, salts, and only a small amount of exosomes, so precipitation methods readily cause co-precipitation, and samples appear dirty under NTA and electron microscopy. For urine, I recommend prioritizing membrane affinity columns or ultrafiltration concentration followed by SEC, rather than direct precipitation. If domestic precipitation kits are chosen for cost and lead time reasons, urine samples should first be thoroughly centrifuged before extraction, preferably with protease inhibitors added and pH adjusted, and the precipitate should be washed one extra time after resuspension. The purity gap is often reflected in these complex samples, rather than the brand itself being inadequate.

Common domestic exosome kit manufacturers include Umibio, Bestbio, Genomeditech, EpiZyme, etc. For specific catalog numbers, you need to inquire according to your sample type. When selecting, require the following: 1) instructions for applicability to cell supernatant and urine; 2) whether a pretreatment column for removing contaminating proteins is available; 3) COAs for different lots; 4) whether trial samples can be provided. Lot-to-lot stability is more critical than certain single purity metrics, especially for long-term cohort samples, as lot fluctuations can introduce false differences. You may ask the manufacturer to provide NTA or protein marker data for three lots, but the final determination should be based on validation with your own samples. It is not recommended to replace an entire batch just because the price is half, buy small packages first and run them in parallel with imported products.